K. Takata

发表

Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.

H. Mabuchi, X. Jiang, Akihiro Inazu, 1994, The Journal of clinical investigation.

Determination of cholesterol and phospholipids of HDL2, HDL3 and VHDL in patients with atherosclerosis and diabetes mellitus.

G. Kajiyama, A. Miyoshi, K. Takata, 1981, Hiroshima journal of medical sciences.

HDL and its subfractions in patients with chronic liver diseases.

G. Kajiyama, I. Horiuchi, A. Miyoshi, 1981, Hiroshima journal of medical sciences.

Fractional esterification rate of cholesterol in high density lipoprotein (HDL) can predict the particle size of low density lipoprotein and HDL in patients with coronary heart disease.

K. Saku, T. Ohta, K. Takata, 1997, Atherosclerosis.

A new case of apoA-I deficiency showing codon 8 nonsense mutation of the apoA-I gene without evidence of coronary heart disease.

R. Liu, K. Arakawa, S. Jimi, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Association of cholesteryl ester transfer protein activity and TaqIB polymorphism with lipoprotein variations in Japanese subjects.

J. Sasaki, N. Yamada, H. Mabuchi, 2003, Metabolism: clinical and experimental.

Structural and functional differences of subspecies of apoA-I-containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency.

S. Horiuchi, T. Ohta, K. Takata, 1995, Journal of lipid research.

Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.

A. Tall, H. Mabuchi, Akihiro Inazu, 1990, The New England journal of medicine.

A splice-junction mutation responsible for familial apolipoprotein A-II deficiency.

S. Deeb, J. Albers, G. Kajiyama, 1990, American journal of human genetics.

Different effects of subclasses of HDL containing apoA-I but not apoA-II (LpA-I) on cholesterol esterification in plasma and net cholesterol efflux from foam cells.

K. Saku, Y. Ikeda, T. Ohta, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Change in constituents in high density lipoprotein and its subfractions in circulation from hepatic vein to femoral artery.

G. Kajiyama, H. Matsuura, F. Hino, 1983, Hiroshima journal of medical sciences.

Structure of the human acyl-CoA:cholesterol acyltransferase-2 (ACAT-2) gene and its relation to dyslipidemia.

T. Ohta, K. Takata, T. Tamura, 2001, Biochimica et biophysica acta.

The effect of experimental hemorrhagic shock on serum HDL-level in rabbits.

G. Kajiyama, H. Matsuura, A. Miyoshi, 1981, Hiroshima journal of medical sciences.

A Fat Meal Test Is Useful to Recognize the Background of Hyperlipidemia

K. Takata, M. Kurahashi, 1993, Annals of the New York Academy of Sciences.

Characterization of subspecies of apolipoprotein A-I-containing lipoprotein in homozygotes for familial lecithin:cholesterol acyltransferase deficiency.

S. Horiuchi, J. Frohlich, Y. Ikeda, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

A new case of familial lecithin: cholesterol acyltransferase (LCAT) deficiency--paradoxical findings regarding LCAT mass and activity in 23 members of a family.

G. Kajiyama, H. Tokumo, I. Horiuchi, 1989, Japanese journal of medicine.

Soluble vascular cell-adhesion molecule-1 and soluble intercellular adhesion molecule-1 correlate with lipid and apolipoprotein risk factors for coronary artery disease in children

K. Saku, N. Adachi, T. Ohta, 1999, European Journal of Pediatrics.

Indices for Prediction of Coronary Sclerosis with Particular Reference to Apo-B/Apo-AI Ratio

G. Kajiyama, H. Matsuura, M. Kawanishi, 1989 .

The influence of the acyl-CoA:cholesterol acyltransferase-1 gene (-77G-->A) polymorphisms on plasma lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects.

T. Ohta, K. Takata, S. Fukuyama, 2004, Biochimica et biophysica acta.

Effects of a new single-nucleotide polymorphism in the Acyl-CoA:cholesterol acyltransferase-2 gene on plasma lipids and apolipoproteins in patients with hyperlipidemia.

T. Ohta, K. Takata, S. Fukuyama, 2003, Journal of atherosclerosis and thrombosis.

4P-1034 A novel nonsense mutation of cholesterol ester transfer protein gene and the clinical characterization of Japanese primary hyperalphalipoproteinemias

Y. Mishima, K. Takata, S. Umemoto, 2003 .

Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1994, The Journal of clinical investigation.

Determination of serum bile acids in hepatobiliary diseases by gas liquid chromatography (fasting serum bile acid levels and endogenous bile acid tolerance test).

G. Kajiyama, I. Horiuchi, A. Miyoshi, 1981, Hiroshima journal of medical sciences.